Close
4

Suanfarma Suanfarma

X

303-97-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
  • Chemistry
303-97-9
Also known as: 303-97-9, Ubiquinone 9, Ubiquinone-9, Coq9, Ubiquinone 45, Ubiquinone q9
Molecular Formula
C54H82O4
Molecular Weight
795.2  g/mol
InChI Key
UUGXJSBPSRROMU-WJNLUYJISA-N
FDA UNII
MGW7TYF2DQ

ubiquinone-9 is a natural product found in Hevea brasiliensis, Pleurotus eryngii, and other organisms with data available.
1 2D Structure

303-97-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione
2.1.2 InChI
InChI=1S/C54H82O4/c1-40(2)22-14-23-41(3)24-15-25-42(4)26-16-27-43(5)28-17-29-44(6)30-18-31-45(7)32-19-33-46(8)34-20-35-47(9)36-21-37-48(10)38-39-50-49(11)51(55)53(57-12)54(58-13)52(50)56/h22,24,26,28,30,32,34,36,38H,14-21,23,25,27,29,31,33,35,37,39H2,1-13H3/b41-24+,42-26+,43-28+,44-30+,45-32+,46-34+,47-36+,48-38+
2.1.3 InChI Key
UUGXJSBPSRROMU-WJNLUYJISA-N
2.1.4 Canonical SMILES
CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
2.1.5 Isomeric SMILES
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
2.2 Other Identifiers
2.2.1 UNII
MGW7TYF2DQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-

2. Coq9

3. Ubiquinone 9

4. Ubiquinone 9, (z,z,z,z,z,e,e,e)-isomer

5. Ubiquinone Q-9

6. Ubiquinone-9

2.3.2 Depositor-Supplied Synonyms

1. 303-97-9

2. Ubiquinone 9

3. Ubiquinone-9

4. Coq9

5. Ubiquinone 45

6. Ubiquinone Q9

7. Ubiquinone-45

8. Coenzyme Q(sub 9)

9. Ubiquinone Q(sub 9)

10. Coq(sub 9)

11. Coenzyme Q(9)

12. Mgw7tyf2dq

13. Chebi:18160

14. Nsc-226993

15. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione

16. Unii-mgw7tyf2dq

17. Nsc 226993

18. Brn 1900081

19. Ubiquinone9

20. Coenzyme-q9

21. Ubiquinone(9)

22. 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione

23. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione

24. Mfcd00056635

25. Ubiquinone Q9 (stn)

26. 4-08-00-03313 (beilstein Handbook Reference)

27. Chembl2252965

28. Ubidecarenone Related Compound A

29. Dtxsid601317880

30. Zinc8217487

31. Lmpr02010004

32. Nsc226993

33. Akos027307694

34. Coenzyme Q9, >=96.0% (hplc)

35. Cs-6359

36. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-

37. 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)-

38. As-77794

39. P-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-

40. P-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (van)

41. Hy-101415

42. Ubidecarenone Impurity D [ep Impurity]

43. C01967

44. Ubidecarenone Related Compound A [usp-rs]

45. J-017946

46. 2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone

47. Q27102857

48. Ubidecarenone Impurity D, European Pharmacopoeia (ep) Reference Standard

49. Ubidecarenone Related Compound A, United States Pharmacopeia (usp) Reference Standard

50. (all-e)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione

51. 2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone

52. 2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)-

53. 3-methyl-5,6-dimethoxy-2-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonene-1-yl)-1,4-benzoquinone

54. P-benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 795.2 g/mol
Molecular Formula C54H82O4
XLogP317.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count28
Exact Mass794.62131109 g/mol
Monoisotopic Mass794.62131109 g/mol
Topological Polar Surface Area52.6 Ų
Heavy Atom Count58
Formal Charge0
Complexity1680
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count8
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY